chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a medical assistant concerning a 20 year old female who on 24-JUL-2008 was vaccinated with the first dose of GARDASIL vaccine (yeast). On 24-JUL-2008 the patient experienced nausea, vomiting and tiredness after received the vaccine. The patient's nausea and vomiting and tiredness persisted. No further information has been requested.
Headache and tired Friday night through  Saturday, injection site painful through Sunday. Saturday through Sunday muscle /ligament ache right side SI joint to  hip. Sunday morning ?night sweats?.
Red face & eyes after vaccine - sneezed for hrs. eye swollen. No wheezing.
Patient came to pharmacy with complaints of extreme arm pain. She states that the vaccine was given high in her shoulder. She states that the pain started upon administration and gradually got worse. Applying pressure to the sight of administration gives her some relief. She has tried to aleviate the pain with APAP and IBU with no relief. She states that heat, not ice, makes it feel better.
Extreme fatigue, headache, muscle and joint pain causing difficulty in moving and walking, nausea with vomiting, hot, red and swollen injection site, all treated with ibuprofen. Most severe pain and fatigue lasted from Saturday afternoon until Monday morning. In creasingly less fatigue and pain through Wednesday evening.
FELT POORLY THE NEXT DAY, BUT NOT REALLY SICK; CHILLS; HEADACHE; FEVER, THE FOLLOWING NIGHT AFTER VACCINATION; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced felt poorly the next day, but not really sick, chills, headache, and fever, the following night after vaccination. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt poorly the next day, but not really sick, chills, headache, and fever, the following night after vaccination. This report was non-serious.
Bit of soreness at the injection site; General malaise; It seems to have cleared my sinuses 100 percent. I feel like my brain is getting so much oxygen and I can breathe normally.; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) dose 2, via an unspecified route of administration, on 20Mar2021 (Batch/Lot number was unknown) as single dose for COVID-19 immunization. Medical history included "sinuses" from an unknown date. Concomitant medication(s) included cetirizine hydrochloride (ALLERGY CARE) taken for sinuses, start and stop date were not reported.  Patient previously received BNT162B2 dose 1, via unspecified route of administration, on unspecified date as single dose for COVID-19 immunization. Patient received the second dose on 20Mar2021. She had a bit of soreness at the injection site, general malaise for 24 hours but the craziest thing was that it seemed to have cleared her sinuses 100 percent (in Mar2021). She felt like her brain was getting so much oxygen and she can breathe normally (she took daily allergy meds for reference). The clinical outcome of soreness at the injection site, general malaise, and cleared her sinuses 100 percent was unknown.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.
repeated cold sores on lip; This case was reported by a consumer via call center representative and described the occurrence of cold sores lip in a 67-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingles vaccine (received her first 2 shingles shots, did not have the name of the vaccine or the date received) and Shingrix (received 1st dose on on 01January 2021).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced cold sores lip. On an unknown date, the outcome of the cold sores lip was not recovered/not resolved.   It was unknown if the reporter considered the cold sores lip to be related to Shingrix.     Additional Information: GSK Receipt Date: 31-JAN-2023 Reporter's Comments: The patient reported case for herself. The patient reported that she received her first 2 shingles shots (patient did not have the name of the vaccine or the date received) and then a year later her pharmacist told her they did not work. The patient then received 2 Shingrix shots. The patient did not have the date for her 2nd Shingrix shot, and said she most likely received the vaccines in her right arm.  The patient had repeated cold sores that start on one side of her lip and would cover almost her entire lip.  The reporter did not consent to follow up.
dizzy; felt warm; my arm became very sore and red; severe chills; muscle aches; headache; fatigued; my arm became very sore; 102 oral temperature; This is a spontaneous report from a contactable consumer (patient). A 68-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot Number: EN9581) via an unspecified route of administration on 19Feb2021 at 11:15 (at the age of 68-years-old) in right arm as a single dose for covid-19 immunization. Medical history included known allergies from penicillin, sulfa and azithromycin all from an unknown date and unknown if ongoing. No other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with covid-19. Post vaccination, the patient had not been tested for covid-19. Concomitant medications included losartan (LOSARTAN); fish oil (FISH OIL) and vitamin d3 (VITAMIN D3) all taken for an unspecified indication, start and stop date were not reported. The patient's historical vaccine included first dose of BNT162B2 (COVID Pfizer vaccine; Lot number: EL3247) on 29Jan2021 at 11:30 in left arm for covid-19 immunization. On 19Feb2021 at 21:30, ten hours after receiving the vaccine her arm became very sore and red. She also developed severe chills, muscle aches and headache. She felt warm but did not check her temperature. She was also dizzy and fatigued. Over the next 24 hours the symptoms continued with lessening chills and headache. That evening she ran 102 oral temperature. The events were reported as non-serious. By the next morning all symptoms were mostly gone with lingering fatigue for 8 more hours. Her arm stayed sore to touch for 3 more days. The patient underwent lab tests and procedures which included body temperature: 102 on 19Feb2021. The patient did not receive any treatment. By day 3 after vaccine all symptoms were completely resolved in Feb2021.  Follow-up attempts completed. No further information expected.
This case was reported by healthcare professional and described the occurrence of wrong vaccine administration in a 7-year-old male subject who was vaccinated with INFANRIX (GlaxoSmithKline). On an unspecified date the subject inadvertently received unspecified dose of INFANRIX (unknown). This was considered to be the wrong vaccine for administration. The child should not have received INFANRIX at the age of 7. At an unspecified time after vaccination with INFANRIX, the child developed a swollen arm. At the time or reporting the outcome of the event was unspecified.
PATIENT STATES HE HAD A METALLIC TASTE IN HIS MOUTH RIGHT AFTER RECEIVING THE VACCINE. HE STATED TODAY THAT HE ALSO TASTED IT AFTER THE FIRST VACCINE DOSE BUT HE DIDN'T THINK ANYTHING OF IT UNTIL TODAY WHEN HE GOT HIS SECOND DOSE.
vaccinated for Hep A but did contract Hep A few years ago; vaccinated for Hep A but did contract Hep A few years ago; This spontaneous report Was received from an other reporter and refers to a female patient of unknown age (also reported as 30's). The patient's concurrent conditions, medical history, concomitant medications, drugs reactions or allergies were not provided.  On an unknown date, the patient was vaccinated with hepatitis A vaccine, inactivated(VAQTA)(dose, route of administration, frequency, lot # and expiration date were not provided) as a hepatitis A prevention. The patient was vaccinated for hepatitis A, but did contract Hepatitis A a few years ago. The outcome of hepatitis A and vaccination failure was unknown.        The causal relationship between adverse events and hepatitis A vaccine, inactivated(VAQTA) was not provided.
Vaccine on 2/24/14, pt with (L) upper arm edema and pain on 2/26/14,
4:30am 3/6/21-fever of 100.2 and nausea/feeling the need to go to bathroom  3/7-present extreme exhaustion, headaches
14 yr old received 5y-11y bivalent booster, no side effects.
Postural orthostatic tachycardia syndrome; kept passing out; Constipation; Blurred vision; loss of words; in a wheelchair; Memory loss; Slurred speech; major fatigue; Headache; Fever chills; extreme dizziness; This is a spontaneous report from a contactable consumer (patient's mother-in-law).   A 39-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: not reported), dose 2 via an unspecified route of administration on an unspecified date in 2021 as single dose for covid-19 immunization (at the age of 39-year-old). The patient medical history was not reported. The patient's concomitant medications were not reported. Patient historical vaccine included first dose of BNT162B2 via an unspecified route of administration on an unspecified date for covid-19 immunization (at the age of 39-year-old). The patient hospitalized for postural orthostatic tachycardia syndrome for 7 days between 24May2021 to 28May2021, kept passing out from May2021 to Jun2021. On an unspecified date in May2021, the patient experienced in a wheelchair and loss of words. He started to have memory loss and slurred speech around the same time of 24May2021 to 28May2021. Her son in law started wearing a helmet when he was released from the hospital. He also started using a wheelchair at that time. He was very weak and dizzy. In order to avoid accidents he was given a prescription for a wheelchair. Her son in law was perfectly healthy prior to this. He also had fever and chills like everyone does. Her son in law had a battery of test at the hospital to rule out any other possible cause. Results are unavailable at this time. Her daughter had the vaccine at the same time and was fine. On an unspecified date in 2021, the patient experienced extreme dizziness, major fatigue, headache, fever chills. On an unspecified date, blurred vision and constipation. The outcome of all the events was not recovered.
Awoke feeling hot, temperature 97.4°, very weak, no energy alternating being chilled and hot without fever. Took acetaminophen which helped. By the afternoon was feeling better.  However the long term effects for 5 days was elevated blood glucose levels that were not responding properly to Humalog premeal injections. It appears that I was more insulin resistant than usual.
Pt presents today 4/1/09 with red area (about baseball - sized) + sl. raised + mild pain on right deltoid - site of MENACTRA  I.M. injection given on 3/31/2009. Symptoms began within hours of injection according to father. Benadryl 1 tsp TID pm + warm / cold compresses to alternate ordered per Doctor.
Shortly after injection, stated that she "felt funny".  She was responsive,  answered questions, did not lose consciousness.  Skin was warm and dry.  She was sitting in the chair and did not require to be placed in a recumbent position.  BP 140/96, HR-76 and regular, Respirations-20.  She was given crackers and water.  at 1:33 pm, BP-142/84, HR-76 and regular, R-20.  1:40 pm BP-142/84, HR-80, R-18.  She was responsive and answering questions appropriately.  She was a ambulatory to her car accompanied by me.  Follow-up telephone call at 4:00, she stated that she was doing fine.  She was referred to her doctor regarding elevated blood pressure.
generalized itching, maculopapular rash,  lips, face, neck, tongue swelling, difficulty of swallowing, left wrist swelling, generalized weakness, fatigue. 2nd dose of vaccine received on 01/11/21, first was on 12/22/20.  Symptoms started on 01/16/21 between 1 and 2 am. First day symptoms were mild resolved after taking allegra and benadryl.  On 01/17/21 between 2 and 3 am started again, and got worse, did not improve after taking allerga and zyrtec. Later in the day started on prednisone daily, allegra daily and one dose of benadryl. Symptoms lasted for few more days
had vax 14JAN93, loss of muscle control w/dec feeling in rt side of face started 15JAN93 @ about 8AM; progressively got worse then started to improve a little in PM of 17JAN94; no tx;
patient states red  swollen arm starting below injection site and continuing to elbow area. Began 1 day after administration and continued for "several days" (exact time frame not given by patient). States took OTC analgesic for pain and discomfort. Stopped when resolved.
PATIENT STARTED WITH A HEADACHE, NAUSEA, AND VOMITTING.
sore arm, from the injection, for only 1-2 days"; left arm discomfort; shoulder pain; This is a spontaneous report from a contactable consumer or other non hcp. A 58-years-old male patient received bnt162b2 (PFIZER; Solution for injection; Lot number: EL3248) dose 1 via an unspecified route of administration, administered in left arm on 24Jan2021 as single dose for COVID-19 immunization. The patient's medical history included Chronic lymphocytic leukemia patient since Jul2015 and disrupt GI. Concomitant medications included ibrutinib taken for chronic lymphocytic leukaemia, meloxicam for arthralgia, flecainide taken for arrhythmia, aciclovir taken for antiviral treatment, guaifenesin, sulfamethoxazole, trimethoprim. The patient had a sore arm, from the injection, for only 1-2 days and was also taking meloxicam daily at the time. He then developed some "GI problems, due to the possible side effects of the meloxicam, and PCP told him to stop taking this medication. The patient stated that on day 8 the soreness reappeared and became worse each day, then on day 10 took a meloxicam and the arm pain was better. The patient stated that he can no longer take the meloxicam and he still had moderately sore. Upon follow up received on 05Feb2021, His oncologist recommended him to get it. 12 days after he got the vaccine his side effect came back. He got it in his left arm. He had left arm discomfort for a couple of days. The discomfort disappeared. He was also taking Meloxicam 7.5mg because he needs his hip replaced. It started to disrupt his GI, so he discontinued it. After he discontinued the Meloxicam, the arm soreness came back. He believes the Meloxicam was masking the shoulder soreness. He discontinued the Meloxicam, and 12 days later after the vaccine, his shoulder pain came back. He thinks once the anti-inflammation medication wore off it came back. His symptoms came back. He was just wondering how long people have been symptomatic after the injection. His next vaccine on 17Feb2021, and his arm was still sore from the first. He felt like this should have been more transient, and in a quicker time frame. The outcome of the events was reported as an unknown.   Follow up received on 05Feb2021: New significant information was received.   Follow-up attempts are completed. No further information is expected.
Information has been received from a registered nurse concerning an outbreak of chickenpox in a child, between the ages of kindergarten to 4th grade, who had vaccinated subcutaneously with a first dose of 0.5 ml of varicella virus vaccine live (Oka/Merck). Subsequently, the child developed chickenpox. The child may have 50 lesions or more. Unspecified medical attention was sought. There was no product quality complaint. Additional information is not expected. This is one of several reports received from the same source.
Facility administered 2 patients expired doses of the Moderna Vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Facility administered 2 patients expired doses of the Moderna Vaccine) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041C21A) for COVID-19 vaccination. No Medical History information was reported.On 03-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Facility administered 2 patients expired doses of the Moderna Vaccine). On 03-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Facility administered 2 patients expired doses of the Moderna Vaccine) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.Concomitant medication information was not provided by the reporter.Treatment information was not provided by the reporter.
COVID 19 PATIENT STATED HE DOESNT HAVE CARD, OR KNOW WHEN HE HAD VACC
Six hours after COVID-19 started having really intense chills for about 3-4 hours.
Clinic reports awoke 12-17-16 in am, brother noticed pale, pink rash to Rt. deltoid area. Client reports itchy feeling. Denies fever, HA, SOB, swelling to face or throat. 12-19-16 to clinic, mild erythema, skin dry, itchy, scaly, no drainage, (color unchanged), temp 97.9 oral.
Pt given an IM injection, became pale and fainted in chair.  Father was holding her at the time. Ammonia inhalant administered and lowered onto pad on floor.  Color pale, clammy skin and regular pulse. Laid flat and feet elevated on a chair.  Immediately regained color and consciousness and answered questions appropriately.  Observed for several minutes.  Sat up and given water and a snack.  Felt dizzy and laid back down for few minutes.  Sat up again and felt fine. Stood up and continued to feel well and maintain color.  Ambulated out with parents. After episode, Pt and parents shared that this happens with every injection and even when losing a tooth.  Explained that it would be helpful to share that prior to any procedure.
Case number PHHY2014US050751, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 518920) website on 24 Apr 2014. This report refers to a female patient of an unknown age. She was vaccinated with Influenza vaccine (manufacturer and season unknown, batch number: not reported) on an unknown date. On an unknown date, after vaccination she experienced hypersensitive reaction. The outcome and causality of the event were not reported. The seriousness of the event was not reported, however the case was internally upgraded as medically significant by the agency.
Injection was more painful than in previous years administered in posterior shoulder. After injection the arm was sore with increasing loss of ROM, strength and increasing pain. Pain, and decreased functional mobility continued to increase with time instead of resolve.
Administer on 11/04/2022 Pfizer Covid Monovalent, on left deltoid No adverse outcome after vaccine administration
headache; Body aches; sore arm; nausea; slight fever; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient (unknown if pregnant) received bnt162b2 (BNT162B2), on 20Jan2021 at 13:00 as dose 2, single (Lot number: EL8982) at the age of 35 years for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: ELINEST taken for contraception. Vaccination history included: bnt162b2 (1st dose, Lot EK9231, Vaccination site: left arm upper, Time: 13:00), administration date: 30Dec2020, when the patient was 35-year-old, for COVID-19 immunisation, reaction(s): "headache", "sore arm". The following information was reported: HEADACHE (non-serious), outcome "unknown"; PAIN (non-serious), outcome "unknown", described as "Body aches"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm"; NAUSEA (non-serious), outcome "unknown"; PYREXIA (non-serious), outcome "unknown", described as "slight fever". Relevant laboratory tests and procedures are available in the appropriate section.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202201152033 same patient and reporter, different dose and event;
Approx 4 weeks after the second dose of SARS Cov 2 vax I started to experience shooting pain in my left hand that started at my wrist below my thumb and shot out my middle finger and thumb. I can only describe it best that it felt like I touched a live wire and 110 volts went through it. The pain was about an 8, painful but short lived. For the first 2 weeks these events were limited to only the left hand but were happening more frequently and more severe, (10+) 2-4X an hour and pain would sometimes put me on my knees until the event subsided (usually within the minute). Then I sarted to have these events in both hands, roughly 7 weeks post vax. my right hand progressed similiarly to the left but at  an accelerated  Additional information for Item 18:  rate. By now I was experiencing these events bilaterally every 5 to 10 mins in my waking hours and it would wake me up several times every night (pain level 10).  I had first contact with my provider on week 8 by phone, on June 8, 2021. We discussed options and went more conservatively with Ibuprofen 600 and chiropractic care. I was unable to follow up with the Chiro due to work. The IB 600 helped with the effects of the episodes but not the frequency. By early August I started to have neuropathology in my left hand fingertips. this has become a hindrance and affects my ability to function with any normalcy daily.  By the 3rd week in August I started having knee dropping and tear producing lower back pain (indescribably painful and way beyond a 10. Several times I passed out from the pain.) that radiated down below my hip joints bilaterally.  As with my hands, these felt like an electrical shock but was a constant low voltage with surges that occurred with movement. IE: standing up, sitting down, bending over, reaching up etc.. I'm not sure about when but eventually the surges in my hands stopped in favor of a constant tingling with numbness in both hands and the constant back and glute pain has resolved as of 01/19/2022 in favor of infrequent acute on chronic events perhaps 6X a day dependent on my activity level.
Injection arm began to hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Injection arm began to hurt) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     Concurrent medical conditions included Tendonitis. Concomitant products included HYDROCHLOROTHIAZIDE and POTASSIUM (POTASSIUM pills) for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (Injection arm began to hurt). At the time of the report, PAIN IN EXTREMITY (Injection arm began to hurt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       It was reported that the patient had lingering arm pain and she could not reach behind her without pain. She would decide after seeing her doctor if the pain was from vaccine or from tendonitis unrelated to the vaccine. The patient took Ibuprofen to lessen the pain.   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: current condition added
Rash that started in armpit and went across chest and back.  Worse  on left side.  Rash is blotchy , itchy, and burns.  Also had diarrhea.  Symptoms started on 1/29/2021 and have started to improved.